Wenqing Yao's Insider Trades & SAST Disclosures
Wenqing Yao's most recent trade in Incyte Corp. was a trade of 15,054 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on July 2, 2021.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Wenqing Yao.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Incyte Corp. | Wenqing Yao | EVP, Head of Discovery Chem | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2021 | 15,054 | 15,054 | - | - | Employee Stock Option (right to buy) | |
| Incyte Corp. | Wenqing Yao | EVP, Head of Discovery Chem | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2021 | 7,853 | 101,933 (0%) | 0% | 0 | Common Stock | |
| Incyte Corp. | Wenqing Yao | EVP, Head of Discovery Chem | Payment of exercise price or tax liability using portion of securities received from the company at price $ 83.58 per share. | 02 Jul 2021 | 2,953 | 98,980 (0%) | 0% | 83.6 | 246,812 | Common Stock |
| Incyte Corp. | Wenqing Yao | EVP, Head of Discovery Chem | Payment of exercise price or tax liability using portion of securities received from the company at price $ 83.34 per share. | 02 Jul 2021 | 405 | 98,575 (0%) | 0% | 83.3 | 33,753 | Common Stock |
| Incyte Corp. | Wenqing Yao | EVP, Head of Discovery Chem | Sale of securities on an exchange or to another person at price $ 85.37 per share. | 28 Jun 2021 | 27,194 | 94,080 (0%) | 0% | 85.4 | 2,321,552 | Common Stock |
| Incyte Corp. | Wenqing Yao | EVP, Head of Discovery Chem | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.61 per share. | 28 Jun 2021 | 22,806 | 121,274 (0%) | 0% | 85.6 | 1,952,422 | Common Stock |
| Incyte Corp. | Wenqing Yao | EVP, Head of Discovery Chem | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2021 | 19,986 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Incyte Corp. | Wenqing Yao | EVP, Head of Discovery Chem | Exercise or conversion of derivative security received from the company (such as an option) at price $ 73.21 per share. | 25 Jan 2021 | 19,986 | 163,770 (0%) | 0% | 73.2 | 1,463,175 | Common Stock |
| Incyte Corp. | Wenqing Yao | EVP, Head of Discovery Chem | Sale of securities on an exchange or to another person at price $ 100.00 per share. | 25 Jan 2021 | 19,986 | 143,784 (0%) | 0% | 100 | 1,998,600 | Common Stock |
| Incyte Corp. | Wenqing Yao | EVP, Head of Discovery Chem | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2021 | 1,559 | 0 | - | - | Incentive Stock Option (right to buy) | |
| Incyte Corp. | Wenqing Yao | EVP, Head of Discovery Chem | Sale of securities on an exchange or to another person at price $ 100.00 per share. | 25 Jan 2021 | 1,559 | 143,784 (0%) | 0% | 100 | 155,900 | Common Stock |
| Incyte Corp. | Wenqing Yao | EVP, Head of Discovery Chem | Exercise or conversion of derivative security received from the company (such as an option) at price $ 73.21 per share. | 25 Jan 2021 | 1,559 | 145,343 (0%) | 0% | 73.2 | 114,134 | Common Stock |
| Incyte Corp. | Wenqing Yao | EVP, Head of Discovery Chem | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 12,743 | 12,743 | - | - | Employee Stock Option (right to buy) | |
| Incyte Corp. | Wenqing Yao | EVP, Head of Discovery Chem | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 11,522 | 143,784 (0%) | 0% | 0 | Common Stock | |
| Incyte Corp. | Wenqing Yao | EVP, Head of Discovery Chem | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Nov 2020 | 1,232 | 156,851 (0%) | 0% | 0 | Common Stock | |
| Incyte Corp. | Wenqing Yao | EVP, Head of Discovery Chem | Payment of exercise price or tax liability using portion of securities received from the company at price $ 104.25 per share. | 15 Jul 2020 | 639 | 155,619 (0%) | 0% | 104.3 | 66,616 | Common Stock |
| Incyte Corp. | Wenqing Yao | EVP, Head of Discovery Chem | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jul 2020 | 15,648 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Incyte Corp. | Wenqing Yao | EVP, Head of Discovery Chem | Sale of securities on an exchange or to another person at price $ 107.32 per share. | 02 Jul 2020 | 15,648 | 156,258 (0%) | 0% | 107.3 | 1,679,343 | Common Stock |
| Incyte Corp. | Wenqing Yao | EVP, Head of Discovery Chem | Exercise or conversion of derivative security received from the company (such as an option) at price $ 64.55 per share. | 02 Jul 2020 | 15,648 | 171,906 (0%) | 0% | 64.5 | 1,010,078 | Common Stock |
| Incyte Corp. | Wenqing Yao | EVP, Head of Discovery Chem | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2020 | 12,743 | 12,743 | - | - | Employee Stock Option (right to buy) | |
| Incyte Corp. | Wenqing Yao | EVP, Head of Discovery Chem | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2020 | 6,661 | 158,849 (0%) | 0% | 0 | Common Stock | |
| Incyte Corp. | Wenqing Yao | EVP, Head of Discovery Chem | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.47 per share. | 02 Jul 2020 | 2,187 | 156,662 (0%) | 0% | 106.5 | 232,850 | Common Stock |
| Incyte Corp. | Wenqing Yao | EVP, Head of Discovery Chem | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jul 2020 | 905 | 0 | - | - | Incentive Stock Option (right to buy) | |
| Incyte Corp. | Wenqing Yao | EVP, Head of Discovery Chem | Sale of securities on an exchange or to another person at price $ 107.32 per share. | 02 Jul 2020 | 905 | 156,258 (0%) | 0% | 107.3 | 97,125 | Common Stock |
| Incyte Corp. | Wenqing Yao | EVP, Head of Discovery Chem | Exercise or conversion of derivative security received from the company (such as an option) at price $ 64.55 per share. | 02 Jul 2020 | 905 | 157,163 (0%) | 0% | 64.6 | 58,418 | Common Stock |
| Incyte Corp. | Wenqing Yao | EVP, Head of Discovery Chem | Payment of exercise price or tax liability using portion of securities received from the company at price $ 107.79 per share. | 02 Jul 2020 | 404 | 156,258 (0%) | 0% | 107.8 | 43,547 | Common Stock |
| Incyte Corp. | Wenqing Yao | EVP, Head of Discovery Chem | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2020 | 25,000 | 152,188 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges